Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
  1. 4 Planned sale Mancini Anthony sold 3,120 shares at an average $132.41 ($413,129)
  2. 4 Planned sale GOLDSMITH MARK A sold 120,000 shares at $150.09 ($18,010,488)
  3. 4 Planned sale Mancini Anthony sold 37,450 shares at an average $95.56 ($3,578,821)
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 4 Planned sale Chief Medical Officer sold 2,073 shares at $99.48 ($206,223)
  7. 4 Planned sale Kelsey Stephen Michael sold 4,302 shares at $99.48 ($427,965)
  8. 4 Planned sale GOLDSMITH MARK A sold 12,871 shares at $99.48 ($1,280,412)
  9. 4 Planned sale Chief Operating Officer sold 4,583 shares at $99.48 ($455,919)
  10. 4 Planned sale Chief Financial Officer sold 2,753 shares at $99.48 ($273,870)
  11. 4 Planned sale General Counsel sold 2,958 shares at an average $98.68 ($291,890)
  12. 4 Planned sale Wang Xiaolin sold 2,010 shares at $99.48 ($199,956)
  13. 4 Gift Director gave 15,000 shares (gift)
  14. 4 Grant or award Wang Xiaolin acquired 15,100 shares (grant or award)
  15. 4 Grant or award Chief Medical Officer acquired 15,100 shares (grant or award)
  16. 4 Grant or award Kelsey Stephen Michael acquired 21,100 shares (grant or award)
  17. 4 Planned sale GOLDSMITH MARK A sold 36,000 shares at an average $101.23 ($3,644,354)
  18. 4 Grant or award Chief Operating Officer acquired 21,100 shares (grant or award)
  19. 4 Grant or award General Counsel acquired 14,500 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 20,200 shares (grant or award)

Page 3 of 21 · 413 filings